Výsledky vyhledávání - "E. Licea Martín"

Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-PLUS: double-blind, randomised, placebo-controlled phase 3 clinical trial

Autor: N. L. Herrera Marrero, V. Verez Bencomo, B. Paredes Moreno, I. C. Mendoza Hernández, R. Duarte González, M. Martínez Pérez, Soberana Phase team, M. Eugenia Toledo-Romani, M. Rodríguez Ortega, W. Baldoquin-Rodriguez, Yury Valdés-Balbín, C. Valenzuela Silva, L. I. Egües Torres, Dagmar García-Rivera, Y. Climent Ruiz, S. García Blanco, P. M. Velazco Villares, K. Idalmis Cisnero, M.C. Rodríguez González, I. Rojas Remedios, O. Samón Tabio, E. Caballero Gonzalez, M. Garcia-Carmenate, S. Pérez Cabrera, S. Huete Ferreira, E. Licea Martín, D. Meliá Pérez, O. Fonte Galindo, R. González-Mujica Romero, S. Fernandez Castillo, J. P. Bacallao Castillo

SUMMARYBackgroundSOBERANA-02 is a COVID-19 conjugate vaccine (recombinant RBD conjugated to tetanus toxoid). Phases 1/2 clinical trials demonstrated high immunogenicity, promoting neutralizing IgG and specific T-cell response. A third heterologous do

Vyhledávací nástroje:

Upřesnit hledání